Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20141127020112N12Phase 3Completed
Phase 3, open-label trial of bupivacaine and sufentanil (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Onset time of sensory block, Onset time of motor block and 5 more. Started Aug 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20141127020112N12.